BIONIME Rightest Blood Glucose Monitoring System | Diabetes
Bionime Selects Sannuo as the strategic partner for China Market

Bionime’s revenue and marketing share will be growing in China after Bionime selects Sinocare Sensing Co.(Sannuo), Ltd as the strategic partner for China Market in Feb. 2014. Bionime has signed the term sheet of distributors agreement and private placement. Based on Sannuo’s advantage in the Retail channels in China, we will create more and higher marketing shares in the future. Our mission is to become the one of the biggest Manufacturer of the world.   

Bionime hold the shareholding meeting and passed the resolution of the private placement on 7th Feb, 2014. The funds from the private placement are used to replenish the company’s working capital or pay off debts to improve the financial structure. Besides, we will continuously develop and improve automatic production equipment and processes, expand and clone production lines timely for rapid growth of business and vertically integrate the supply of (raw) materials along the supply chain. According to BOD meeting minutes, Bionime selects Sannuo as the strategic partner and Sannuo will subscribe no more than 11,000,000 shares at NTD120 per share. Bionime and Sannuo will proceed the following procedures according to related government rules.   

Sannuo invests Bionime for Bionime’s unique technologic skills, patents , high quality products and global marketing expertise. Bionime and Sannuo will cooperate for the long term strategy in the future to build a leading global brand, especially in China. Bionime will set up a factory line in China for the rapid growth in the following year.   


About Bionime
Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. BIONIME integrates top-tier expertise in medical science, chemistry, electronics and precision engineering to commercialize our patented noble metal, biosensor technology used in our meters and test strips. Today, BIONIME employs more than 500 people and operates 4 subsidiaries in Europe, the Americas, Australia and Asia. Our products have been shown to meet or exceed the highest standards of accuracy and precision in numerous independent studies published in leading international clinical journals.  Bionime products are distributed worldwide and are available in all the major markets.  For more information please visit our Web Site at

Sinocare sensing Co., Ltd.

Sinocare Inc. is a new high-tech company dedicated to bio-sensing technology research, development, production and instant sales of detection product. In March, 2012, the company was listed on Shenzhen Stock Exchange; its share is abbreviated as "Sinocare", stock code 300298. The company passes ISO : 13485 quality management system and EU CE certification and wins support from the national innovation fund for multiple times; besides, the company assumes the high tech industrialization demonstration project in national bio-medical engineering.

  Keep me signed in(Public or not to check the total pre-computer)  
    Forgot username Forgot Password